Skip to main content
Top
Published in: Clinical Rheumatology 1/2012

01-01-2012 | Original Article

The subclinic autonomic dysfunction in patients with Behçet disease: an electrophysiological study

Authors: Pınar Borman, Figen Tuncay, Seher Kocaoğlu, Müyesser Okumuş, Emel Güngör, Meral Ekşioğlu

Published in: Clinical Rheumatology | Issue 1/2012

Login to get access

Abstract

Studies that have evaluated autonomic nervous system (ANS) function in Behçet disease (BD) are rare and have indicated conflicting results with different degrees of involvement. The aim of this study was to investigate ANS function by using electrophysiological tests in patients with BD and to determine the relationship between the disease activity parameters and the indicators of autonomic activity. We included 70 BD patients and 50 healthy controls. Demographic characteristics including age, sex, and disease duration were recorded. A detailed neurological examination was performed, and clinical autonomic symptoms were recorded. The Behçet Disease Current Activity Form (BDCAF) was used to determine the disease activity. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels were determined for laboratory activity. The electrophysiological assessments of ANS function were performed by sympathetic skin response (SSR) and R-R interval variation (RRIV) tests. The mean values of sympathetic (SSR latency and amplitude) and parasympathetic (RRIV at rest [R%] and deep breathing [D%], D% − R%, and D%/R%) parameters were compared, and any correlations between ANS parameters and clinical disease characteristics were determined. Seventy BD patients (23 males, 47 females) with a mean age of 41.2 ± 10.01 years and 50 control subjects (18 males, 32 females) with a mean age of 39.5 ± 8.94 years were included in the study. All the subjects were totally symptom free with respect to ANS involvement, and the subjects in both groups had normal neurological examination findings. The demographic characteristics were similar between the groups. The mean latency of SSR was increased (1.4 ± 0.4 vs 0.7 ± 0.8), and R% (0.3 ± 0.3 vs 0.5 ± 0.4) and D% (0.3 ± 0.3 vs 0.6 ± 0.5) values were decreased in BD patients compared to control subjects. No correlation was found between BDCAF scores and ANS variables. However, there was a significant correlation between SSR latency and ESR and CRP values (p < 0.01, r = −0.25, r = −0.31, respectively) in the patient group, indicating a more sympathetic dysautonomia in patients with active laboratory parameters. In conclusion, our study indicates a subclinical sympathetic and parasympathetic autonomic dysfunction in patients with BD, which may be related with disease activity. As the early recognition of abnormalities in ANS may be very important in order to prevent excessive morbidity, simple electrophysiological methods are suggested to identify Behçet patients at high risk for symptomatic dysautonomia.
Literature
1.
go back to reference Behçet’s H (1937) Uber rezidivierende aphthouse durch ein virus verursachte Geschwuere am Mund, Auge und an den Genitalien. Dermatol Monatsschr 105:1152–1157 Behçet’s H (1937) Uber rezidivierende aphthouse durch ein virus verursachte Geschwuere am Mund, Auge und an den Genitalien. Dermatol Monatsschr 105:1152–1157
2.
go back to reference Yurdakul S, Hamuryudan V, Fresko I, Yazici H (2008) Behçet’s syndrome. In: Hochberg MC, Silman AJ, Smolen JS et al (eds) Rheumatology, 4th edn. Mosby-Elsevier, Philadelphia, pp 1559–1564 Yurdakul S, Hamuryudan V, Fresko I, Yazici H (2008) Behçet’s syndrome. In: Hochberg MC, Silman AJ, Smolen JS et al (eds) Rheumatology, 4th edn. Mosby-Elsevier, Philadelphia, pp 1559–1564
3.
go back to reference Akman-Demir G, Serdaroğlu P, Tasci B (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 122(Pt 11):2171–2182PubMedCrossRef Akman-Demir G, Serdaroğlu P, Tasci B (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 122(Pt 11):2171–2182PubMedCrossRef
4.
go back to reference Akbulut L, Gur G, Bodur H, Alli N, Borman P (2007) Peripheral neuropathy in Behçet disease: an electroneurophysiological study. Clin Rhematol 26(8):1240–1244CrossRef Akbulut L, Gur G, Bodur H, Alli N, Borman P (2007) Peripheral neuropathy in Behçet disease: an electroneurophysiological study. Clin Rhematol 26(8):1240–1244CrossRef
5.
go back to reference Bayramlar H, Hepŝen IF, Uğuralp M, Bölük A, Ozcan C (1998) Autonomic nervous system involvement in Behçet’s disease: a pupillometric study. J Neuroophthalmol 18(3):182–186PubMedCrossRef Bayramlar H, Hepŝen IF, Uğuralp M, Bölük A, Ozcan C (1998) Autonomic nervous system involvement in Behçet’s disease: a pupillometric study. J Neuroophthalmol 18(3):182–186PubMedCrossRef
6.
go back to reference Aksoyek S, Aytemir K, Ozer N, Ozcebe O, Oto A (1999) Assessment of autonomic nervous system function in patients with Behcet’s disease by spectral analysis of heart rate variability. J Auton Nerv Syst 77(2–3):190–194CrossRef Aksoyek S, Aytemir K, Ozer N, Ozcebe O, Oto A (1999) Assessment of autonomic nervous system function in patients with Behcet’s disease by spectral analysis of heart rate variability. J Auton Nerv Syst 77(2–3):190–194CrossRef
7.
go back to reference Karataş GK, Onder M, Meray J (2002) Autonomic nervous system involvement in Behçet’s disease. Rheumatol Int 22(4):155–159, Epub 2002 Jul 2PubMedCrossRef Karataş GK, Onder M, Meray J (2002) Autonomic nervous system involvement in Behçet’s disease. Rheumatol Int 22(4):155–159, Epub 2002 Jul 2PubMedCrossRef
8.
go back to reference Akyol M, Turaclar U, Kececi H, Ozcelik S, Marufihah M, Erdal S, Polat M (2002) Electrodermal activities and autonomic nervous system in Behçet’s patients. Neurol Sci 23(2):55–58PubMedCrossRef Akyol M, Turaclar U, Kececi H, Ozcelik S, Marufihah M, Erdal S, Polat M (2002) Electrodermal activities and autonomic nervous system in Behçet’s patients. Neurol Sci 23(2):55–58PubMedCrossRef
9.
go back to reference Ozdemir R, Sezgin AT, Topal E, Kutlu R, Barutcu I, Gullu H (2003) Findings of ambulatory blood pressure monitoring and heart rate variability in patients with Behçet’s disease. Am J Cardiol 92(5):646–648PubMedCrossRef Ozdemir R, Sezgin AT, Topal E, Kutlu R, Barutcu I, Gullu H (2003) Findings of ambulatory blood pressure monitoring and heart rate variability in patients with Behçet’s disease. Am J Cardiol 92(5):646–648PubMedCrossRef
10.
go back to reference Gulturk S, Akyol M, Kececi H, Ozcelik S, Cinar Z, Demirkazik A (2008) Delayed habituation in Behcet’s disease. Neurol India 56(1):27–30PubMedCrossRef Gulturk S, Akyol M, Kececi H, Ozcelik S, Cinar Z, Demirkazik A (2008) Delayed habituation in Behcet’s disease. Neurol India 56(1):27–30PubMedCrossRef
11.
go back to reference Kırımlı O, Aslan O, Göldeli O, Güneri S, Badak O, Fetil E, Ozkan S (2000) Heart rate variability, late potentials and QT dispersion as markers of myocardial involvement in patients with Behçet’s disease. Can J Cardiol 16(3):345–351PubMed Kırımlı O, Aslan O, Göldeli O, Güneri S, Badak O, Fetil E, Ozkan S (2000) Heart rate variability, late potentials and QT dispersion as markers of myocardial involvement in patients with Behçet’s disease. Can J Cardiol 16(3):345–351PubMed
12.
go back to reference Tellioglu T, Robertson D (2001) Orthostatic intolerance in Behcet’s disease. Auton Neurosci 89(1–2):96–99PubMedCrossRef Tellioglu T, Robertson D (2001) Orthostatic intolerance in Behcet’s disease. Auton Neurosci 89(1–2):96–99PubMedCrossRef
13.
go back to reference Kaya EB, Yorgun H, Akdogan A et al (2009) Heart rate recovery index is impaired in Behçet’s disease. Tex Heart Inst J 36(4):282–286PubMed Kaya EB, Yorgun H, Akdogan A et al (2009) Heart rate recovery index is impaired in Behçet’s disease. Tex Heart Inst J 36(4):282–286PubMed
14.
go back to reference International Study Group for Behçet’s Disease (1992) Evaluation of diagnostic classification criteria in Behçet’s disease—towards internationally agreed criteria. Br J Rheumatol 31:299–308CrossRef International Study Group for Behçet’s Disease (1992) Evaluation of diagnostic classification criteria in Behçet’s disease—towards internationally agreed criteria. Br J Rheumatol 31:299–308CrossRef
15.
go back to reference Lawton GB, Bhakta MA, Chamberlain A, Tennant A (2004) The Behçet’s disease activity index. Rheumatology 43:73–78PubMedCrossRef Lawton GB, Bhakta MA, Chamberlain A, Tennant A (2004) The Behçet’s disease activity index. Rheumatology 43:73–78PubMedCrossRef
16.
go back to reference Hamuryudan V, Fresko I, Direskeneli H, Tenant MJ, Yurdakul S, Akoglu T, Yazici H (1999) Evaluation of the Turkish translation of a disease activity form for Behçet’s syndrome. Rheumatology (Oxford) 38(8):734–736CrossRef Hamuryudan V, Fresko I, Direskeneli H, Tenant MJ, Yurdakul S, Akoglu T, Yazici H (1999) Evaluation of the Turkish translation of a disease activity form for Behçet’s syndrome. Rheumatology (Oxford) 38(8):734–736CrossRef
17.
go back to reference Shahani BT, Day TJ, Cros D, Khalil N, Kneebone CS (1990) RR interval variation and the sympathetic skin response in the assessment of autonomic function in peripheral neuropathy. Arch Neurol 47(6):659–664PubMedCrossRef Shahani BT, Day TJ, Cros D, Khalil N, Kneebone CS (1990) RR interval variation and the sympathetic skin response in the assessment of autonomic function in peripheral neuropathy. Arch Neurol 47(6):659–664PubMedCrossRef
18.
go back to reference Shahani BT, Halperin JJ, Boulu P et al (1984) Sympathetic skin response. A method of assessing unmyelinated axon dysfunction in peripheral neuropathies. J Neurol Neurosurg Psychiatry 47:536–542PubMedCrossRef Shahani BT, Halperin JJ, Boulu P et al (1984) Sympathetic skin response. A method of assessing unmyelinated axon dysfunction in peripheral neuropathies. J Neurol Neurosurg Psychiatry 47:536–542PubMedCrossRef
19.
go back to reference Borman P, Gokoglu F, Kocaoglu S, Yorgancioglu ZR (2008) The autonomic dysfunction in patients with ankylosing spondylitis: a clinical and electrophysiological study. Clin Rheumatol 27(10):1267–1273PubMedCrossRef Borman P, Gokoglu F, Kocaoglu S, Yorgancioglu ZR (2008) The autonomic dysfunction in patients with ankylosing spondylitis: a clinical and electrophysiological study. Clin Rheumatol 27(10):1267–1273PubMedCrossRef
20.
go back to reference Tuncay F, Borman F, Kocaoğlu S, Yorgancıoğlu RZ (2009) The autonomic dysfunction in patients with rheumatoid arthritis: a clinical and electrophysiological study. Romatol Tıp Rehab 20(3):77–83 Tuncay F, Borman F, Kocaoğlu S, Yorgancıoğlu RZ (2009) The autonomic dysfunction in patients with rheumatoid arthritis: a clinical and electrophysiological study. Romatol Tıp Rehab 20(3):77–83
21.
go back to reference Aydemir M, Yazisiz V, Basarici I, Avci AB, Erbasan F, Belgi A, Terzioglu E (2010) Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus. Lupus 19(3):255–261PubMedCrossRef Aydemir M, Yazisiz V, Basarici I, Avci AB, Erbasan F, Belgi A, Terzioglu E (2010) Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus. Lupus 19(3):255–261PubMedCrossRef
22.
go back to reference El-Sayed ZA, Mostafa GA, Aly GS, El-Shahed GS, El-Aziz MM, El-Emam SM (2009) Cardiovascular autonomic function assessed by autonomic function tests and serum autonomic neuropeptides in Egyptian children and adolescents with rheumatic diseases. Rheumatology (Oxford) 48(7):843–848CrossRef El-Sayed ZA, Mostafa GA, Aly GS, El-Shahed GS, El-Aziz MM, El-Emam SM (2009) Cardiovascular autonomic function assessed by autonomic function tests and serum autonomic neuropeptides in Egyptian children and adolescents with rheumatic diseases. Rheumatology (Oxford) 48(7):843–848CrossRef
23.
go back to reference Coşkun B, Saral Y, Gödekmerdan A et al (2005) Activation markers in Behçet disease. Skinmed 4(5):282–286PubMedCrossRef Coşkun B, Saral Y, Gödekmerdan A et al (2005) Activation markers in Behçet disease. Skinmed 4(5):282–286PubMedCrossRef
24.
go back to reference Yazıcı C, Köse K, Çalış M et al (2004) Increased advanced oxidation protein products in Behçet’s disease: a new activity marker? Br J Dermatol 15(1):105–111 Yazıcı C, Köse K, Çalış M et al (2004) Increased advanced oxidation protein products in Behçet’s disease: a new activity marker? Br J Dermatol 15(1):105–111
25.
go back to reference Piha SJ, Voipio-Pulkku LM (1993) Elevated resting heart rate in rheumatoid arthritis: possible role of deconditioning. Br J Rheumatol 32:212–215PubMedCrossRef Piha SJ, Voipio-Pulkku LM (1993) Elevated resting heart rate in rheumatoid arthritis: possible role of deconditioning. Br J Rheumatol 32:212–215PubMedCrossRef
26.
go back to reference Tan J, Akin S, Beyazova M et al (1993) Sympathetic skin response and R-R interval variation in rheumatoid arthritis: two simple tests for the assessment of autonomic function. Am J Physical Med Rehab 72:196–203CrossRef Tan J, Akin S, Beyazova M et al (1993) Sympathetic skin response and R-R interval variation in rheumatoid arthritis: two simple tests for the assessment of autonomic function. Am J Physical Med Rehab 72:196–203CrossRef
27.
go back to reference Ozgocmen S, Yoldas T, Yigiter R et al (2006) R-R interval variation and sympathetic skin response in fibromyalgia. Archieves Med Res 37:630–634CrossRef Ozgocmen S, Yoldas T, Yigiter R et al (2006) R-R interval variation and sympathetic skin response in fibromyalgia. Archieves Med Res 37:630–634CrossRef
28.
go back to reference Persson A, Solders G (1983) R-R variations: a test of autonomic dysfunction. Acta Neurol Scand 67:285–293PubMedCrossRef Persson A, Solders G (1983) R-R variations: a test of autonomic dysfunction. Acta Neurol Scand 67:285–293PubMedCrossRef
29.
go back to reference Knezevic W, Bajada S (1985) Peripheral autonomic surface potential. A quantitative technique for recording sympathetic condition in men. J Neurol Sci 67:239–251PubMedCrossRef Knezevic W, Bajada S (1985) Peripheral autonomic surface potential. A quantitative technique for recording sympathetic condition in men. J Neurol Sci 67:239–251PubMedCrossRef
30.
go back to reference Shahabi S, Hassan ZM, Jazani NH et al (2006) Sympathetic nervous system plays an important role in the relationship between immune mediated diseases. Med Hypotheses 67:900–903PubMedCrossRef Shahabi S, Hassan ZM, Jazani NH et al (2006) Sympathetic nervous system plays an important role in the relationship between immune mediated diseases. Med Hypotheses 67:900–903PubMedCrossRef
31.
go back to reference Goldstein RS, Bruchfield A, Yang L et al (2007) Cholinergic antiinflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med 13:210–215PubMedCrossRef Goldstein RS, Bruchfield A, Yang L et al (2007) Cholinergic antiinflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med 13:210–215PubMedCrossRef
32.
go back to reference Shoemaker JK, Hogeman CS, Khan M et al (2001) Gender affects sympathetic and hemodynamic response to postural stress. Am J Physiol Heart Circ Physiol 281:H2028–H2035PubMed Shoemaker JK, Hogeman CS, Khan M et al (2001) Gender affects sympathetic and hemodynamic response to postural stress. Am J Physiol Heart Circ Physiol 281:H2028–H2035PubMed
33.
go back to reference Jones PP, Spraul M, Matt KS et al (1996) Gender does not influence sympathetic neural reactivity to stress in healthy humans. Am J Physiol Heart Circ Physiol 270:H350–H357 Jones PP, Spraul M, Matt KS et al (1996) Gender does not influence sympathetic neural reactivity to stress in healthy humans. Am J Physiol Heart Circ Physiol 270:H350–H357
Metadata
Title
The subclinic autonomic dysfunction in patients with Behçet disease: an electrophysiological study
Authors
Pınar Borman
Figen Tuncay
Seher Kocaoğlu
Müyesser Okumuş
Emel Güngör
Meral Ekşioğlu
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2012
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1763-9

Other articles of this Issue 1/2012

Clinical Rheumatology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.